News

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...
After blueprinting an injectables facility in North Carolina in 2020, it didn’t take long for Eli Lilly to draw up designs ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Key Points Energy, healthcare, and chip stocks have driven the market higher today. Tesla has stopped falling and has recovered slightly due to the Musk-Trump feud cooling down. Many stocks have made ...
Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an overreaction to GLP-1 news.
Lilly affirmed its full-year revenue guidance, but lowered its profit forecasts. Last quarter , it said it expected 2025 revenue between $58.0 to $61.0 billion, with EPS from $22.05 to $23.55, and ...
But Eli Lilly CEO David Ricks waved off the deal Thursday, ... QCOM reported adjusted earnings per share of $2.85, edging past Wall Street’s forecast of $2.82, Revenue also came in above expectations, ...
Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade' ... QCOM reported adjusted earnings per share of $2.85, edging past Wall Street’s forecast of $2.82, ...
QCOM, LLY, MCD lag after earnings. Dow +172.81 at 40842.17, Nasdaq +333.91 at 17780.25, S&P +51.93 at 5620.99 ... The loss in Eli Lilly has contributed to the underperformance of the S&P 500 health ...
Eli Lilly reports 1Q earnings on Thursday, with EPS of $3.05 and revenues of $12.67 billion expected. Stock is up 14.35% in past year.
Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...
April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs ...